electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study
electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study December 08, 2020 08:00 ET | Source: electroCore electroCore Basking Ridge, New Jersey, UNITED STATES BASKING RIDGE, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today top-line results from its GM-US-10 (PREMIUM II) study. Despite the early termination of the study in April 2020 due to the COVID-19 pandemic, all study endpoints, including several patient-assessed qualit...
Source: globenewswire.com